CORR Insights®: A Tool to Estimate Risk of 30-day Mortality and Complications After Hip Fracture Surgery: Accurate for Some but Not All Purposes? A Study From the ACS-NSQIP Database

医学 髋部骨折 梅德林 数据库 外科 内科学 骨质疏松症 政治学 计算机科学 法学
作者
Matthew L. Webb
出处
期刊:Clinical Orthopaedics and Related Research [Ovid Technologies (Wolters Kluwer)]
卷期号:480 (12): 2347-2349
标识
DOI:10.1097/corr.0000000000002340
摘要

Where Are We Now? Hip fractures are common, and most patients with hip fractures treated operatively will have better outcomes than those treated nonoperatively [2]. Beside the well-known mortality benefit, patients treated with surgery are discharged from the hospital earlier, are more likely to have healed fractures without shortening or deformity, and are more likely to return to their preinjury level of independence [4]. But because patients with hip fractures present with a variety of demographic and comorbid characteristics, a patient-individualized risk assessment or decision tool would be useful. Harris et al. [5] used the American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database to create and internally validate a freely available online tool to predict the likelihoods of 30-day postoperative mortality and major complications after operative treatment of hip fractures. Patient age, gender, BMI, and 14 other patient-specific health characteristics were used to compute patient-individualized risks. The authors found an overall incidence of mortality of 5% and reported good-to-fair performance and calibration of their model after tenfold internal cross-validation. The authors concluded this tool could be useful for personalized informed consent and shared decision-making with patients and their families. Where Do We Need To Go? Predictive tools run into a number of typical issues when they seek to determine the likelihood of rare events. For example, if the expected risk of death for all-comers is 5%, then a model that simply predicts all patients will survive will be correct 95% of the time. Such a model looks great on paper, but it would be of little clinical utility. Among patient-individualized risk prediction tools that are available online, the tool of Harris et al. [5] offers some interface and usability advantages compared with the online tool available directly from the ACS (http://www.riskcalculator.facs.org/RiskCalculator/). Although this tool may not enhance all informed consent processes, one could imagine referring especially analytically minded or tech-savvy patients and families to this tool to help them understand the gravity of the injury. As the boundaries of research questions and topics expand, it is important that researchers continue to exercise care in their use of big data. One set of concerns pertains to biases and discrimination associated with race and ethnicity [1, 14]. For example, Harris et al. [5] noted that 79% of patients in their study identified as White, while recent United States Census data found that fewer than 62% of all Americans identified as White [13]. Although the discrepancy is almost certainly incidental, the ACS-NSQIP sample does not necessarily represent the population of the United States in terms of racial or ethnic distribution. Large databases may underrepresent some Americans, and these discrepancies could induce major biases depending on the regions of interest, populations or outcomes studied, and how carefully and critically researchers interpret the data. The most important biases may be related to inherent differences between the hospitals that report data to the ACS-NSQIP database and the remaining majority of hospitals in the United States that do not contribute data. Although Harris et al. [5] used tenfold internal validation techniques, it is unclear how well their model would perform if it were validated using an external database such as the ACS-National Trauma Data Bank or ACS-Trauma Quality Improvement Program, Agency for Healthcare Research Quality’s National Inpatient Sample, the National Hospital Discharge Survey of the Centers for Disease Control, or even a database based on administrative claims data such as PearlDiver, MarketScan, or Centers for Medicare & Medicaid Service’s Medicare standard analytic files. How Do We Get There? Given the concerns about the unpredictable impact of reporting idiosyncrasies in various databases, perhaps a good strategy for external validation would be the use of local institutional data in the region, hospital, or practice of interest. For example, a recent study attempted to externally validate six models that predict 30-day mortality after hip fracture against their own institutional data [8], and the authors found that none of the models they studied would have been effective predicting mortality among patients who underwent hip fracture surgery at their hospital. Perhaps the most useful predictive models for a particular location would be those built using the data from patients in that state, region, institution, or integrated health plan. Moving forward, predictive models should be continuously refined, validated, and compared in order to account for changing trends and treatments [6, 11], epidemiology and demographics [7, 12], and even health pandemics [3, 9]. For example, after increased mortality was recognized in patients who tested positive for COVID-19 and were treated for hip fractures, New York University’s Langone Medical Center added COVID-19 as a predictor to their Score for Trauma Triage in the Geriatric and Middle-Aged [9]. Databases should be curated to represent the patients we treat and the outcomes that are important to us and our patients. The major criticisms that are applicable to any ACS-NSQIP study are that the follow-up period is too short (30 days) and there is no nonoperative comparison group. A lack of a nonoperative control group limits our ability to compare the prognoses of patients treated operatively with those treated nonoperatively [10]. Perhaps in the future, a governmental agency, academic collaborative group, or large integrated healthcare organization could create a trauma registry that longitudinally follows patients treated operatively and nonoperatively. But until that day, the most accurate and useful scoring systems and predictive models may be those created using local data.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
阳谷光完成签到,获得积分10
6秒前
7秒前
一一一完成签到 ,获得积分10
15秒前
20秒前
21秒前
ZOEY发布了新的文献求助10
25秒前
东拉西扯发布了新的文献求助10
25秒前
25秒前
tina完成签到,获得积分10
27秒前
宇宙之王宙斯完成签到 ,获得积分10
29秒前
学术疯子发布了新的文献求助10
32秒前
32秒前
33秒前
一往之前发布了新的文献求助10
37秒前
小方发布了新的文献求助10
39秒前
胖胖完成签到 ,获得积分10
40秒前
烟花应助tina采纳,获得10
40秒前
tosuto house完成签到 ,获得积分10
41秒前
sfx完成签到 ,获得积分10
43秒前
隐形曼青应助一往之前采纳,获得10
43秒前
慕青应助豆浆烩面采纳,获得10
45秒前
淇奥完成签到,获得积分10
45秒前
46秒前
CipherSage应助annoraz采纳,获得10
47秒前
48秒前
东拉西扯发布了新的文献求助10
57秒前
sf完成签到 ,获得积分10
59秒前
1分钟前
平安喜乐完成签到,获得积分20
1分钟前
1分钟前
碧蓝雁风发布了新的文献求助10
1分钟前
Hubery完成签到 ,获得积分10
1分钟前
平安喜乐关注了科研通微信公众号
1分钟前
一往之前发布了新的文献求助10
1分钟前
1分钟前
1分钟前
1分钟前
JamesPei应助科研通管家采纳,获得10
1分钟前
JamesPei应助科研通管家采纳,获得30
1分钟前
高分求助中
LNG地下式貯槽指針(JGA Guideline-107)(LNG underground storage tank guidelines) 1000
Generalized Linear Mixed Models 第二版 1000
rhetoric, logic and argumentation: a guide to student writers 1000
QMS18Ed2 | process management. 2nd ed 1000
Asymptotically optimum binary codes with correction for losses of one or two adjacent bits 800
Preparation and Characterization of Five Amino-Modified Hyper-Crosslinked Polymers and Performance Evaluation for Aged Transformer Oil Reclamation 700
Operative Techniques in Pediatric Orthopaedic Surgery 510
热门求助领域 (近24小时)
化学 医学 材料科学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 物理化学 催化作用 免疫学 细胞生物学 电极
热门帖子
关注 科研通微信公众号,转发送积分 2925566
求助须知:如何正确求助?哪些是违规求助? 2572967
关于积分的说明 6948704
捐赠科研通 2225945
什么是DOI,文献DOI怎么找? 1183024
版权声明 589080
科研通“疑难数据库(出版商)”最低求助积分说明 578900